GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TCON
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for TRACON Pharmaceuticals stock price on Friday moving between $1.93 and $2.14
(Updated on Apr 19, 2024)

Buy or Hold candidate since Apr 11, 2024 Loss -24.32% PDF

The TRACON Pharmaceuticals stock price fell by -7.11% on the last day (Friday, 19th Apr 2024) from $2.11 to $1.96. During the last trading day the stock fluctuated 10.88% from a day low at $1.93 to a day high of $2.14. The price has fallen in 8 of the last 10 days but is still up by 667.72% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -113 thousand shares and in total, 237 thousand shares were bought and sold for approximately $465.41 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 83.72% during the next 3 months and, with a 90% probability hold a price between $0.652 and $5.83 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TCON Signals & Forecast

The TRACON Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.12. On a fall, the stock will find some support from the long-term average at approximately $0.768. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 10, 2024, and so far it has fallen -34.88%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for TRACON Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.80 and $1.71. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $1.71 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.210 between high and low, or 10.88%. For the last week the stock has had daily average volatility of 29.50%.

Our recommended stop-loss: $1.85 (-5.72%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (TCON) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect TRACON Pharmaceuticals to open at $2.01, and during the day (based on 14 day Average True Range), to move between $1.58 and $2.34, which gives a possible trading interval of +/-$0.383 (+/-19.55%) up or down from last closing price. If TRACON Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 39.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.11 (7.65%) than the support at $1.80 (8.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is TRACON Pharmaceuticals stock A Buy?

TRACON Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.584 Hold/Accumulate Downgraded

Predicted Opening Price for TRACON Pharmaceuticals of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$2.01 ( 2.55%) $1.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TCON

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.22 13.27 %
R2 2.14 9.17 %
R1 2.09 6.64 %
Current price: 1.96
Support S1 1.93 -1.54 %
S2 1.88 -4.07 %
S3 1.80 -8.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.36 20.41 %
R2 2.29 16.84 %
R1 2.11 7.65 %
Current price 1.96
Support S1 1.80 -8.16%
S2 1.71 -12.76%
S3 0 .

FAQ

What is the symbol for TRACON Pharmaceuticals Stock and on which exchange is it traded?
The symbol for TRACON Pharmaceuticals is TCON and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TRACON Pharmaceuticals Stock?
TRACON Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy TRACON Pharmaceuticals Stock?
TRACON Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TRACON Pharmaceuticals Stock.

What's the current price of TRACON Pharmaceuticals Stock?
As of the end of day on the 2024-04-19, the price of an TRACON Pharmaceuticals (TCON) share was $1.96.

What is the 52-week high and low for TRACON Pharmaceuticals Stock?
The 52-week high for TRACON Pharmaceuticals Stock is $3.37 and the 52-week low is $0.126.

What is the market capitalization of TRACON Pharmaceuticals Stock?
As of the 2024-04-19, the market capitalization of TRACON Pharmaceuticals is 89.189M.

When is the next earnings date for TRACON Pharmaceuticals?
The upcoming earnings date for TRACON Pharmaceuticals is May 08, 2024.
Click to get the best stock tips daily for free!

About TRACON Pharmaceuticals

TRACON Pharmaceuticals TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also... TCON Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT